Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$34,210.00
Jul 24, 2023
For-profit organization
ARP - Enhanced Analytical Methods Development
1008024
Sigma’s upcoming project focuses on going above and beyond the minimum quality requirements set by Health Canada for cannabis products. The goal is to develop a set of analytical methods to address the advancements and growing demand in the cannabis markets. As new products and specifications for quality control bring more requirements to existing testing landscape, Sigma focused activities will cover a variety of sought after methods, some being the addition of elements, solvents, cannabinoids and terpenes to expand existing methods to meet USP requirements. Other activities would span as large as the ground-up development of new methods for newly found and required-to-test contaminations being addressed in quality control for production.
$200,000.00
Apr 1, 2022
For-profit organization
Development and Validation of Analytical and Extraction Methods to Support Production, Safety and Efficacy, as well as Scientific Advancement in Bringing Cannabis-derived and Psychedelics-based New Pr
991023
NAICS Code should be 772313 as a testing lab for Cannabis.
This NAICS code is not update in Sonar yet. Commercial-level development and validation (Per Health Canada’s Requirements) of a set of analytical methods to measure the quantity of multiple active ingredients (cannabinoids and psychedelics in raw Material and finished products), microbial and other harmful contaminations in selected cannabis-derived product matrices and psychedelics intended for therapeutic use, and development and optimization of extraction, purification and synthetic manufacturing of psychedelic compounds.
$48,871.00
Jul 27, 2021
For-profit organization
Commercial Level Validation (Per Health Canada’s Requirements) of a Set of Analytical Methods for Measuring the Quantity of multiple Active ingredients (Cannabinoids) in Selected Cannabis Derived Product Matrices Designed for Therapeutic Use
977217
This project will result in the validation, to a degree acceptable for commercialization as an analytical service, of a set of analytical methods for measuring the quality of selected cannabinoid containing edibles and topicals designed for therapeutic use. Quality in this context refers to the cannabinoid content of the products, as the acknowledged active ingredient(s).